Navigation Links
NJIT patent may be able to replace BPA, make consumer products safer
Date:2/25/2010

Michael Jaffe, a professor of biomedical engineering at NJIT, has received a patent for a chemical derived from sugar. This new material is a derivative of isosorbide and may be able to replace bisphenol A (BPA) in a number of consumer products, including the lining of tin cans.

Jaffe has been developing the material in conjunction with the Iowa Corn Promotion Board (ICPB) in an effort to promote and create new, commercially attractive, sustainable chemistries from wider uses of corn. This new sugar derivative can be obtained from corn. This is the first patent in a series filed by ICPB and NJIT to develop applications and markets for sugar-based chemistry.

"Exposure to bisphenol A has been linked to health problems and we feel confident that this is a safe alternative," said Rodney Williamson, director of research and development for the board.

Much attention has recently focused on BPA, which has been known to have estrogenic properties since the 1930s. BPA is widely used in processes that result in the lining for tin cans and key ingredients in plastics ranging from baby bottles to nail polish.

Unfortunately, the chemical bonds that link BPA in polymer structures are not completely stable and the polymer may slowly decay with time, releasing small amounts of it into materials with which it comes into contact, such as food or water. Recent studies have shown the widespread presence of tiny amounts of BPA in the environment. Even at minute levels BPA may still exert estrogen-like effects on living organisms.

The new invention is an epoxy resin. These are polymers widely used as adhesives, paints and as coatings to protect food in cans. This invention describes a renewable resource epoxy, derived, for example, from isosorbide, a sustainable chemical that can be synthesized from corn starch. Both components of the epoxythe resin and the hardenerare from water-soluble, plant-derived chemistries. The epoxy is cured by baking at an elevated temperature.

"We are viewing sugars as a chemical feedstock to produce new monomers, polymers and additives for a broad range of biomedical industrial applications," said Jaffe. "Sugar-based chemicals are attractive because they are generally regarded as safe, are a renewable resource and can be made readily available at competitive pricing.

Isosorbide offers molecular geometry and chemical functionality compatible with many existing commercial chemistries."


'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert  

Related biology news :

1. bioMETRX, Inc. Acquires Patent for Biometric Padlock
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
4. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
5. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
6. Cornell patents a pink lily look-alike that blooms all summer long
7. Biotechnology needs 21st century patent system: Expert
8. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
9. US Patent Office rejects companys claim for bean commonly grown by Latin American farmers
10. bioMETRX, Inc. Files for Several New Patents
11. Scripps Research Institute awarded patent for remarkable chemical technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NJIT patent may be able to replace BPA, make consumer products safer
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
Breaking Biology Technology: